Comment
|
In microglia treated with IFN-gamma, iNOS protein expression was significantly suppressed in cells treated with ACM compared with non-pretreated cells.
|
Formal Description Interaction-ID: 8263
|
|
Drugbank entries
|
Show/Hide entries for
IFNG
or
NOS2
|
Drugbank
DB01250
|
|
Drugbank
DB01296
|
|
Drugbank
DB00125
|
|
Drugbank
DB00155
|
|
Drugbank
DB01110
|
|
Drugbank
DB01234
|
|
Drugbank
DB01686
|
|
Drugbank
DB01835
|
4r-Fluoro-N6-Ethanimidoyl-L-Lysine
|
Drugbank
DB01997
|
|
Drugbank
DB02044
|
N-(3-(Aminomethyl)Benzyl)Acetamidine
|
Drugbank
DB02207
|
|
Drugbank
DB02234
|
|
Drugbank
DB02462
|
|
Drugbank
DB02533
|
|
Drugbank
DB02539
|
|
Drugbank
DB02644
|
N-Omega-Propyl-L-Arginine
|
Drugbank
DB02692
|
(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin
|
Drugbank
DB03014
|
|
Drugbank
DB03100
|
|
Drugbank
DB03144
|
N-Omega-Hydroxy-L-Arginine
|
Drugbank
DB03271
|
|
Drugbank
DB03449
|
N-(4-(2-((3-Chlorophenylmethyl)Amino)Eth ...
|
Drugbank
DB03953
|
|
Drugbank
DB04400
|
|
Drugbank
DB04534
|
|
Drugbank
DB06879
|
5-(4'-AMINO-1'-ETHYL-5',8'-DIFLUORO-1'H- ...
|
Drugbank
DB06916
|
N-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-1-[2-( ...
|
Drugbank
DB07002
|
4-({4-[(4-methoxypyridin-2-yl)amino]pipe ...
|
Drugbank
DB07003
|
(2S)-2-methyl-2,3-dihydrothieno[2,3-f][1 ...
|
Drugbank
DB07007
|
(3R)-3-[(1,2,3,4-tetrahydroisoquinolin-7 ...
|
Drugbank
DB07008
|
4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMI ...
|
Drugbank
DB07011
|
(3S)-1-(1,3-BENZODIOXOL-5-YLMETHYL)-3-[4 ...
|
Drugbank
DB07029
|
4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMI ...
|
Drugbank
DB07306
|
ETHYL 4-[(4-CHLOROPYRIDIN-2-YL)AMINO]PIP ...
|
Drugbank
DB07318
|
N-[2-(4-AMINO-5,8-DIFLUORO-1,2-DIHYDROQU ...
|
Drugbank
DB07388
|
ETHYL 4-[(4-METHYLPYRIDIN-2-YL)AMINO]PIP ...
|
Drugbank
DB07389
|
N-[2-(6-AMINO-4-METHYLPYRIDIN-2-YL)ETHYL ...
|
Drugbank
DB07405
|
1-(6-CYANO-3-PYRIDYLCARBONYL)-5',8'-DIFL ...
|
Drugbank
DB08214
|
4-(1H-IMIDAZOL-1-YL)PHENOL
|
Drugbank
DB08750
|
1-[4-(AMINOMETHYL)BENZOYL]-5'-FLUORO-1'H ...
|
Drugbank
DB08814
|
|
Drugbank
DB00125
|
|
Drugbank
DB00155
|
|
Drugbank
DB01686
|
|
Drugbank
DB01835
|
4r-Fluoro-N6-Ethanimidoyl-L-Lysine
|
Drugbank
DB01997
|
|
Drugbank
DB02207
|
|
Drugbank
DB02234
|
|
Drugbank
DB02533
|
|
Drugbank
DB02539
|
|
Drugbank
DB02644
|
N-Omega-Propyl-L-Arginine
|
Drugbank
DB02692
|
(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin
|
Drugbank
DB03014
|
|
Drugbank
DB03100
|
|
Drugbank
DB03144
|
N-Omega-Hydroxy-L-Arginine
|
Drugbank
DB03271
|
|
Drugbank
DB03953
|
|
Drugbank
DB04400
|
|
Drugbank
DB04534
|
|
|
|
Comment
|
In microglia treated with IFN-gamma, iNOS protein expression was significantly suppressed in cells treated with ACM compared with non-pretreated cells.
|
Formal Description Interaction-ID: 8264
|
in microglia; after induction of iNOS via interferon-gamma
|
Drugbank entries
|
Show/Hide entries for
NOS2
|
Drugbank
DB00125
|
|
Drugbank
DB00155
|
|
Drugbank
DB01110
|
|
Drugbank
DB01234
|
|
Drugbank
DB01686
|
|
Drugbank
DB01835
|
4r-Fluoro-N6-Ethanimidoyl-L-Lysine
|
Drugbank
DB01997
|
|
Drugbank
DB02044
|
N-(3-(Aminomethyl)Benzyl)Acetamidine
|
Drugbank
DB02207
|
|
Drugbank
DB02234
|
|
Drugbank
DB02462
|
|
Drugbank
DB02533
|
|
Drugbank
DB02539
|
|
Drugbank
DB02644
|
N-Omega-Propyl-L-Arginine
|
Drugbank
DB02692
|
(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin
|
Drugbank
DB03014
|
|
Drugbank
DB03100
|
|
Drugbank
DB03144
|
N-Omega-Hydroxy-L-Arginine
|
Drugbank
DB03271
|
|
Drugbank
DB03449
|
N-(4-(2-((3-Chlorophenylmethyl)Amino)Eth ...
|
Drugbank
DB03953
|
|
Drugbank
DB04400
|
|
Drugbank
DB04534
|
|
Drugbank
DB06879
|
5-(4'-AMINO-1'-ETHYL-5',8'-DIFLUORO-1'H- ...
|
Drugbank
DB06916
|
N-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-1-[2-( ...
|
Drugbank
DB07002
|
4-({4-[(4-methoxypyridin-2-yl)amino]pipe ...
|
Drugbank
DB07003
|
(2S)-2-methyl-2,3-dihydrothieno[2,3-f][1 ...
|
Drugbank
DB07007
|
(3R)-3-[(1,2,3,4-tetrahydroisoquinolin-7 ...
|
Drugbank
DB07008
|
4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMI ...
|
Drugbank
DB07011
|
(3S)-1-(1,3-BENZODIOXOL-5-YLMETHYL)-3-[4 ...
|
Drugbank
DB07029
|
4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMI ...
|
Drugbank
DB07306
|
ETHYL 4-[(4-CHLOROPYRIDIN-2-YL)AMINO]PIP ...
|
Drugbank
DB07318
|
N-[2-(4-AMINO-5,8-DIFLUORO-1,2-DIHYDROQU ...
|
Drugbank
DB07388
|
ETHYL 4-[(4-METHYLPYRIDIN-2-YL)AMINO]PIP ...
|
Drugbank
DB07389
|
N-[2-(6-AMINO-4-METHYLPYRIDIN-2-YL)ETHYL ...
|
Drugbank
DB07405
|
1-(6-CYANO-3-PYRIDYLCARBONYL)-5',8'-DIFL ...
|
Drugbank
DB08214
|
4-(1H-IMIDAZOL-1-YL)PHENOL
|
Drugbank
DB08750
|
1-[4-(AMINOMETHYL)BENZOYL]-5'-FLUORO-1'H ...
|
Drugbank
DB08814
|
|
Drugbank
DB00125
|
|
Drugbank
DB00155
|
|
Drugbank
DB01686
|
|
Drugbank
DB01835
|
4r-Fluoro-N6-Ethanimidoyl-L-Lysine
|
Drugbank
DB01997
|
|
Drugbank
DB02207
|
|
Drugbank
DB02234
|
|
Drugbank
DB02533
|
|
Drugbank
DB02539
|
|
Drugbank
DB02644
|
N-Omega-Propyl-L-Arginine
|
Drugbank
DB02692
|
(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin
|
Drugbank
DB03014
|
|
Drugbank
DB03100
|
|
Drugbank
DB03144
|
N-Omega-Hydroxy-L-Arginine
|
Drugbank
DB03271
|
|
Drugbank
DB03953
|
|
Drugbank
DB04400
|
|
Drugbank
DB04534
|
|
|
|